KDR and neoplasm: VEGFR2 immunoreactivity was relatively modest in <10% of the nontumor brain vessels, whereas the levels and proportions of immunostaining were increased in vessels at the tumor periphery and were far greater in the tumor center (Fig. 2a and Supplementary Fig. 2j).